申请人:Lupin Limited
公开号:EP3736277A1
公开(公告)日:2020-11-11
Disclosed are compounds of the general formula (I),
wherein R1-R3 are as defined herein, for use as MALT1 inhibitors in the treatment of autoimmune and inflammatory diseases or disorders. Methods of synthesizing the compounds are also disclosed. Also disclosed are pharmaceutical compositions containing a compound of the invention and a method of treating a patient for an autoimmune or an inflammatory disease or disorder, for example, a cancer, by administering a compound of the invention.
所公开的是通式 (I) 的化合物、
其中 R1-R3 如本文所定义,可用作治疗自身免疫性和炎症性疾病或紊乱的 MALT1 抑制剂。还公开了合成这些化合物的方法。还公开了含有本发明化合物的药物组合物,以及通过施用本发明化合物治疗自身免疫或炎症性疾病或紊乱(例如癌症)患者的方法。